Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study.

@article{Sawlani2010GlioblastomaAM,
  title={Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study.},
  author={Rahul N Sawlani and Jeffrey K Raizer and Sandra W Horowitz and Wanyong Shin and Sean A. Grimm and James P. Chandler and Robert Levy and Christopher C. Getch and Timothy J. Carroll},
  journal={Radiology},
  year={2010},
  volume={255 2},
  pages={622-8}
}
PURPOSE To derive a magnetic resonance (MR)-based imaging metric that reflects local perfusion changes resulting from the administration of angiogenic-inhibiting chemotherapy in patients with recurrent glioblastoma multiforme (GBM). MATERIALS AND METHODS In this retrospective Institutional Review Board-approved HIPAA-compliant study, 16 patients (12 men, four women; mean age, 51.8 years + or - 15.1 [standard deviation]) with recurrent GBM received bevacizumab every 3 weeks (15 mg per kilogram… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

Similar Papers

Loading similar papers…